Tiliroside

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

替利罗苷具有抗氧化和抗炎活性，可以抑制神经退行性疾病中的神经炎症。

Tiliroside shows anticarcinogenic activity. Tiliroside shows hepatoprotective activity. Tiliroside shows antioxidant and anti-inflammatory activity, can inhibit neuroinflammation in neurodegenerative disorders. Tiliroside has anti-diabetic effect, are at least partially mediated through inhibitory effects on carbohydrate digestion and glucose uptake in the gastrointestinal tract. Tiliroside and gnaphaliin are antioxidants against in vitro Cu(2+)-induced LDL oxidation in the same order of magnitude compared to that of the reference drug, probucol. Tiliroside enhances fatty acid oxidation via the enhancement adiponectin signaling associated with the activation of both AMP-activated protein kinase and peroxisome proliferator-activated receptor α and ameliorates obesity-induced metabolic disorders.

——

——

——

Metabolic Enzyme/Protease

P450

Antioxidant

Others-Field

——

20316-62-5

594.52

C30H26O13

>98% (HPLC)

In Vitro:?DMSO : 250 mg/mL (420.51 mM)

C1=CC(=CC=C1C=CC(=O)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC=C(C=C5)O)O)O)O)O

——

(-20℃)

With Ice Pack

≥ 2 years